Profusa Inc. (PFSA)
PFSA trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.28
-1.54% on the day
Market cap
$775K
Nano cap
Revenue · 2024
$100K
No prior year to compare
Net income · 2024
-$9.2M
-9230.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | PFSA on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001859807 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $100K |
| Net income | -$9.2M |
| Operating income | -$4.5M |
| Net margin | -9230.0% |
| Operating margin | -4500.0% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $191K |
| Total assets | $3.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 7.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B3 | 2026-07-07 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-04-15 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-19 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-09 |
| Latest proxy PROXY STATEMENT | DEF 14A | 2026-08-28 |
Source: SEC EDGAR submissions feed, 321 recent filings. All filings on EDGAR.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GCTK | GlucoTrack Inc. | $1.11 | -4.31% | $942K |
| NXGL | NexGel Inc | $4.05 | +6.30% | $2.0M |
| XAIR | Beyond Air Inc. | $2.19 | -5.20% | $2.1M |
| VJET | Flyte Aviation Inc. | $1.06 | +6.00% | $2.2M |
| IVF | INVO Fertility Inc. | $0.6399 | -11.86% | $2.9M |
| ADGM | Adagio Medical Holdings Inc | $0.1253 | -5.08% | $3.4M |
| BJDX | Bluejay Diagnostics Inc. | $0.8323 | +5.06% | $3.7M |
| ICCM | IceCure Medical Ltd. | $1.10 | +1.85% | $3.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier